Krystal J Alligood

Meeting the rigorous demands of biosimilar pharmacokinetics

Saara Mansouri, Jennifer Zemo, Krystal J Alligood, 2017 .

A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)

Krystal J Alligood, Karen Lackey, K. Lackey, 2004, Cancer Research.

Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways

Hong Ma, Krystal J Alligood, G. Owens, 2002, Oncogene.